identifying novel digital measures for fatigue and sleep disturbances that will provide more objective, sensitive and reliable measures of the severity and impact of these symptoms in the person’s normal surrounding.

2 Clinical Validation Study

one year longitudinal study with approximately 2000 subjects will be conducted

3 Participant Recruitment

Participants with neurological or immunological disorders from various countries will be screened and recruited

4 Participant visits at the recruitment center

Participants with neurological or immunological disorders from various countries will be screened and recruited

5 Wearing devices at home

All participants will be given a combination of 2-4 digital devices for use in their own environment for several periods

6 Data Collection

Data on fatigue, sleep, selected activities of daily living and other relevant contextual information will be collected by smartphone several times a day while using the devices

7 Data Analysis

In order to establish which devices are suitable for use, complex data analysis will be performed

8 Validation of devices

The devices that met the criteria will be considered for future use in clinical trials

9 Share & Use

The novel clinically validated digital endpoint will be able to:

  • offer deeper insight into disease impact
  • lead to faster clinical development of new therapies
  • provide a more valid and complete assessment of the impact of diseases and treatments

Latest News


IDEA-FAST will be represented at the annual IBD-DACH congress (inflammatory bowel disease, Germany, Austria, Switzerland). Professor Fai Ng is going to give a presentation on IDEA-FAST as an overview on eHealth in general and the

Read More »

IDEA-FAST Science Showcase

On 1st December 2021, IDEA-FAST invited its consortium members to join an internal Science Showcase. The aim of the Science Showcase was to review the Feasibility Study (FS) data and brainstorm the next analysis steps

Read More »


Join IDEA-FAST clinical lead, Walter Maetzler, for a seminar on “Digital biomarkers for chronic diseases: Lessons learned”, as part of the WideHealth series ( https://t.co/IcEqz96d98). Tomorrow, 17th May, at 16:00 CET. Free registration at https://t.co/1Lg8MSm2DG @NeurogeriatricK
Professor Fai Ng @Faing07 is introducing our project to #IBD Inflammatory Bowel Disease specialists in Frankfurt at the annual IBD-DACH meeting on 22 Jan 2022. More info: https://t.co/bVNywwLpDs


There are no upcoming events.